<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-06-01" modified="2020-10-07" version="208">
<accession>P35398</accession>
<accession>P35397</accession>
<accession>P35399</accession>
<accession>P45445</accession>
<accession>Q495X4</accession>
<accession>Q96H83</accession>
<name>RORA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Nuclear receptor ROR-alpha</fullName>
</recommendedName>
<alternativeName>
<fullName>Nuclear receptor RZR-alpha</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear receptor subfamily 1 group F member 1</fullName>
</alternativeName>
<alternativeName>
<fullName>RAR-related orphan receptor A</fullName>
</alternativeName>
<alternativeName>
<fullName>Retinoid-related orphan receptor-alpha</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">RORA</name>
<name type="synonym">NR1F1</name>
<name type="synonym">RZRA</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Genes Dev." volume="8" first="538" last="553">
<title>Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors.</title>
<authorList>
<person name="Giguere V."/>
<person name="Tini M."/>
<person name="Flock G."/>
<person name="Ong E."/>
<person name="Evans R.M."/>
<person name="Otulakowski G."/>
</authorList>
<dbReference type="PubMed" id="7926749"/>
<dbReference type="DOI" id="10.1101/gad.8.5.538"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<scope>FUNCTION AS TRANSCRIPTION ACTIVATOR</scope>
<scope>DNA-BINDING</scope>
<scope>SUBUNIT</scope>
<source>
<tissue>Retina</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1993" name="Biochem. Biophys. Res. Commun." volume="194" first="1371" last="1379">
<title>Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences.</title>
<authorList>
<person name="Becker-Andre M."/>
<person name="Andre E."/>
<person name="Delamarter J.F."/>
</authorList>
<dbReference type="PubMed" id="7916608"/>
<dbReference type="DOI" id="10.1006/bbrc.1993.1976"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Umbilical vein endothelial cell</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2010-12" db="EMBL/GenBank/DDBJ databases">
<title>Isolation of cDNA coding for multiple human nuclear receptor clones.</title>
<authorList>
<person name="Kaighin V.A."/>
<person name="Martin A.L."/>
<person name="Aronstam R.S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Kidney</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Nature" volume="440" first="671" last="675">
<title>Analysis of the DNA sequence and duplication history of human chromosome 15.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Sharpe T."/>
<person name="Young S.K."/>
<person name="Rowen L."/>
<person name="O'Neill K."/>
<person name="Whittaker C.A."/>
<person name="Kamal M."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Kodira C.D."/>
<person name="Madan A."/>
<person name="Qin S."/>
<person name="Yang X."/>
<person name="Abbasi N."/>
<person name="Abouelleil A."/>
<person name="Arachchi H.M."/>
<person name="Baradarani L."/>
<person name="Birditt B."/>
<person name="Bloom S."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Burke J."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dorris L. III"/>
<person name="Dors M."/>
<person name="Eichler E.E."/>
<person name="Engels R."/>
<person name="Fahey J."/>
<person name="Fleetwood P."/>
<person name="Friedman C."/>
<person name="Gearin G."/>
<person name="Hall J.L."/>
<person name="Hensley G."/>
<person name="Johnson E."/>
<person name="Jones C."/>
<person name="Kamat A."/>
<person name="Kaur A."/>
<person name="Locke D.P."/>
<person name="Madan A."/>
<person name="Munson G."/>
<person name="Jaffe D.B."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Mauceli E."/>
<person name="Naylor J.W."/>
<person name="Nesbitt R."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Ratcliffe A."/>
<person name="Rounsley S."/>
<person name="She X."/>
<person name="Sneddon K.M.B."/>
<person name="Stewart S."/>
<person name="Sougnez C."/>
<person name="Stone S.M."/>
<person name="Topham K."/>
<person name="Vincent D."/>
<person name="Wang S."/>
<person name="Zimmer A.R."/>
<person name="Birren B.W."/>
<person name="Hood L."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16572171"/>
<dbReference type="DOI" id="10.1038/nature04601"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 4)</scope>
<source>
<tissue>Muscle</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1997" name="Mol. Endocrinol." volume="11" first="1737" last="1746">
<title>Transcriptional activation and repression by RORalpha, an orphan nuclear receptor required for cerebellar development.</title>
<authorList>
<person name="Harding H.P."/>
<person name="Atkins G.B."/>
<person name="Jaffe A.B."/>
<person name="Seo W.J."/>
<person name="Lazar M.A."/>
</authorList>
<dbReference type="PubMed" id="9328355"/>
<dbReference type="DOI" id="10.1210/mend.11.11.0002"/>
</citation>
<scope>FUNCTION AS TRANSCRIPTION ACTIVATOR</scope>
<scope>INTERACTION WITH NCOR1</scope>
<scope>DNA-BINDING</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="Mol. Endocrinol." volume="13" first="1550" last="1557">
<title>Coactivators for the orphan nuclear receptor RORalpha.</title>
<authorList>
<person name="Atkins G.B."/>
<person name="Hu X."/>
<person name="Guenther M.G."/>
<person name="Rachez C."/>
<person name="Freedman L.P."/>
<person name="Lazar M.A."/>
</authorList>
<dbReference type="PubMed" id="10478845"/>
<dbReference type="DOI" id="10.1210/mend.13.9.0343"/>
</citation>
<scope>FUNCTION AS TRANSCRIPTION ACTIVATOR</scope>
<scope>INTERACTION WITH MED1 AND NCOA2</scope>
<scope>MUTAGENESIS OF VAL-335 AND 510-LEU-PHE-511</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="Nucleic Acids Res." volume="27" first="411" last="420">
<title>Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD.</title>
<authorList>
<person name="Lau P."/>
<person name="Bailey P."/>
<person name="Dowhan D.H."/>
<person name="Muscat G.E."/>
</authorList>
<dbReference type="PubMed" id="9862959"/>
<dbReference type="DOI" id="10.1093/nar/27.2.411"/>
</citation>
<scope>FUNCTION IN MYOGENESIS</scope>
<scope>INTERACTION WITH EP300</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="287" first="383" last="390">
<title>Identification of a novel peroxisome proliferator-activated receptor (PPAR) gamma promoter in man and transactivation by the nuclear receptor RORalpha1.</title>
<authorList>
<person name="Sundvold H."/>
<person name="Lien S."/>
</authorList>
<dbReference type="PubMed" id="11554739"/>
<dbReference type="DOI" id="10.1006/bbrc.2001.5602"/>
</citation>
<scope>FUNCTION AS TRANSCRIPTION ACTIVATOR</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="EMBO Rep." volume="2" first="42" last="48">
<title>The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response.</title>
<authorList>
<person name="Delerive P."/>
<person name="Monte D."/>
<person name="Dubois G."/>
<person name="Trottein F."/>
<person name="Fruchart-Najib J."/>
<person name="Mariani J."/>
<person name="Fruchart J.C."/>
<person name="Staels B."/>
</authorList>
<dbReference type="PubMed" id="11252722"/>
<dbReference type="DOI" id="10.1093/embo-reports/kve007"/>
</citation>
<scope>FUNCTION IN INFLAMMATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="2865" last="2871">
<title>Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha.</title>
<authorList>
<person name="Raspe E."/>
<person name="Duez H."/>
<person name="Gervois P."/>
<person name="Fievet C."/>
<person name="Fruchart J.C."/>
<person name="Besnard S."/>
<person name="Mariani J."/>
<person name="Tedgui A."/>
<person name="Staels B."/>
</authorList>
<dbReference type="PubMed" id="11053433"/>
<dbReference type="DOI" id="10.1074/jbc.m004982200"/>
</citation>
<scope>FUNCTION IN TRIGLYCERIDE METABOLISM</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="52511" last="52518">
<title>The co-repressor hairless protects RORalpha orphan nuclear receptor from proteasome-mediated degradation.</title>
<authorList>
<person name="Moraitis A.N."/>
<person name="Giguere V."/>
</authorList>
<dbReference type="PubMed" id="14570920"/>
<dbReference type="DOI" id="10.1074/jbc.m308152200"/>
</citation>
<scope>FUNCTION AS TRANSCRIPTION ACTIVATOR</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF LYS-357; LEU-361; VAL-364 AND GLU-509</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="15025" last="15031">
<title>Hypoxia-induced activation of the retinoic acid receptor-related orphan receptor alpha4 gene by an interaction between hypoxia-inducible factor-1 and Sp1.</title>
<authorList>
<person name="Miki N."/>
<person name="Ikuta M."/>
<person name="Matsui T."/>
</authorList>
<dbReference type="PubMed" id="14742449"/>
<dbReference type="DOI" id="10.1074/jbc.m313186200"/>
</citation>
<scope>INDUCTION BY HYPOXIA (ISOFORM 4)</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2005" name="Arterioscler. Thromb. Vasc. Biol." volume="25" first="1186" last="1192">
<title>Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalpha.</title>
<authorList>
<person name="Genoux A."/>
<person name="Dehondt H."/>
<person name="Helleboid-Chapman A."/>
<person name="Duhem C."/>
<person name="Hum D.W."/>
<person name="Martin G."/>
<person name="Pennacchio L.A."/>
<person name="Staels B."/>
<person name="Fruchart-Najib J."/>
<person name="Fruchart J.C."/>
</authorList>
<dbReference type="PubMed" id="15790933"/>
<dbReference type="DOI" id="10.1161/01.atv.0000163841.85333.83"/>
</citation>
<scope>FUNCTION IN TRIGLYCERIDE METABOLISM</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="330" first="233" last="241">
<title>Identification of the human ApoAV gene as a novel RORalpha target gene.</title>
<authorList>
<person name="Lind U."/>
<person name="Nilsson T."/>
<person name="McPheat J."/>
<person name="Stroemstedt P.E."/>
<person name="Bamberg K."/>
<person name="Balendran C."/>
<person name="Kang D."/>
</authorList>
<dbReference type="PubMed" id="15781255"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.02.151"/>
</citation>
<scope>FUNCTION IN TRIGLYCERIDE METABOLISM</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="2901" last="2908">
<title>RORA, a large common fragile site gene, is involved in cellular stress response.</title>
<authorList>
<person name="Zhu Y."/>
<person name="McAvoy S."/>
<person name="Kuhn R."/>
<person name="Smith D.I."/>
</authorList>
<dbReference type="PubMed" id="16462772"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209314"/>
</citation>
<scope>FUNCTION IN CELL GROWTH</scope>
<scope>INDUCTION BY CELLULAR STRESS</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Biochem. Biophys. Res. Commun." volume="358" first="890" last="896">
<title>Extracellular signal-regulated kinase-2 phosphorylates RORalpha4 in vitro.</title>
<authorList>
<person name="Lechtken A."/>
<person name="Hoernig M."/>
<person name="Werz O."/>
<person name="Corvey N."/>
<person name="Zoendorf I."/>
<person name="Dingermann T."/>
<person name="Brandes R."/>
<person name="Steinhilber D."/>
</authorList>
<dbReference type="PubMed" id="17512500"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2007.05.016"/>
</citation>
<scope>PHOSPHORYLATION AT THR-183</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF THR-183</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Arterioscler. Thromb. Vasc. Biol." volume="28" first="1796" last="1802">
<title>Transcriptional activation of HIF-1 by RORalpha and its role in hypoxia signaling.</title>
<authorList>
<person name="Kim E.J."/>
<person name="Yoo Y.G."/>
<person name="Yang W.K."/>
<person name="Lim Y.S."/>
<person name="Na T.Y."/>
<person name="Lee I.K."/>
<person name="Lee M.O."/>
</authorList>
<dbReference type="PubMed" id="18658046"/>
<dbReference type="DOI" id="10.1161/atvbaha.108.171546"/>
</citation>
<scope>FUNCTION IN HYPOXIA SIGNALING</scope>
<scope>INTERACTION WITH HIF1A</scope>
<scope>INDUCTION BY HYPOXIA</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Immunol." volume="180" first="4785" last="4792">
<title>Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3.</title>
<authorList>
<person name="Du J."/>
<person name="Huang C."/>
<person name="Zhou B."/>
<person name="Ziegler S.F."/>
</authorList>
<dbReference type="PubMed" id="18354202"/>
<dbReference type="DOI" id="10.4049/jimmunol.180.7.4785"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FOXP3</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF 510-LEU-PHE-511</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="J. Neurochem." volume="104" first="1321" last="1332">
<title>Phosphorylation and transcriptional activity regulation of retinoid-related orphan receptor alpha 1 by protein kinases C.</title>
<authorList>
<person name="Duplus E."/>
<person name="Gras C."/>
<person name="Soubeyre V."/>
<person name="Vodjdani G."/>
<person name="Lemaigre-Dubreuil Y."/>
<person name="Brugg B."/>
</authorList>
<dbReference type="PubMed" id="18005000"/>
<dbReference type="DOI" id="10.1111/j.1471-4159.2007.05074.x"/>
</citation>
<scope>FUNCTION AS TRANSCRIPTION ACTIVATOR</scope>
<scope>PHOSPHORYLATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Biochem. Biophys. Res. Commun." volume="378" first="513" last="517">
<title>SUMOylation of RORalpha potentiates transcriptional activation function.</title>
<authorList>
<person name="Hwang E.J."/>
<person name="Lee J.M."/>
<person name="Jeong J."/>
<person name="Park J.H."/>
<person name="Yang Y."/>
<person name="Lim J.S."/>
<person name="Kim J.H."/>
<person name="Baek S.H."/>
<person name="Kim K.I."/>
</authorList>
<dbReference type="PubMed" id="19041634"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.11.072"/>
</citation>
<scope>SUMOYLATION AT LYS-240</scope>
<scope>MUTAGENESIS OF LYS-240 AND LYS-441</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Nucl. Recept. Signal." volume="7" first="3" last="35">
<title>Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism.</title>
<authorList>
<person name="Jetten A.M."/>
</authorList>
<dbReference type="PubMed" id="19381306"/>
<dbReference type="DOI" id="10.1621/nrs.07003"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="5013" last="5025">
<title>Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands.</title>
<authorList>
<person name="Wang Y."/>
<person name="Kumar N."/>
<person name="Solt L.A."/>
<person name="Richardson T.I."/>
<person name="Helvering L.M."/>
<person name="Crumbley C."/>
<person name="Garcia-Ordonez R.D."/>
<person name="Stayrook K.R."/>
<person name="Zhang X."/>
<person name="Novick S."/>
<person name="Chalmers M.J."/>
<person name="Griffin P.R."/>
<person name="Burris T.P."/>
</authorList>
<dbReference type="PubMed" id="19965867"/>
<dbReference type="DOI" id="10.1074/jbc.m109.080614"/>
</citation>
<scope>FUNCTION IN GLUCOSE METABOLISM REGULATION</scope>
<scope>IDENTIFICATION OF LIGANDS</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="J. Biol. Rhythms" volume="26" first="187" last="199">
<title>Modulation of clock gene expression by the transcriptional coregulator receptor interacting protein 140 (RIP140).</title>
<authorList>
<person name="Poliandri A.H."/>
<person name="Gamsby J.J."/>
<person name="Christian M."/>
<person name="Spinella M.J."/>
<person name="Loros J.J."/>
<person name="Dunlap J.C."/>
<person name="Parker M.G."/>
</authorList>
<dbReference type="PubMed" id="21628546"/>
<dbReference type="DOI" id="10.1177/0748730411401579"/>
</citation>
<scope>INTERACTION WITH NRIP1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="Nature" volume="472" first="491" last="494">
<title>Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.</title>
<authorList>
<person name="Solt L.A."/>
<person name="Kumar N."/>
<person name="Nuhant P."/>
<person name="Wang Y."/>
<person name="Lauer J.L."/>
<person name="Liu J."/>
<person name="Istrate M.A."/>
<person name="Kamenecka T.M."/>
<person name="Roush W.R."/>
<person name="Vidovic D."/>
<person name="Schuerer S.C."/>
<person name="Xu J."/>
<person name="Wagoner G."/>
<person name="Drew P.D."/>
<person name="Griffin P.R."/>
<person name="Burris T.P."/>
</authorList>
<dbReference type="PubMed" id="21499262"/>
<dbReference type="DOI" id="10.1038/nature10075"/>
</citation>
<scope>FUNCTION IN T(H)17 CELLS DIFFERENTIATION</scope>
<scope>IDENTIFICATION OF LIGANDS</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="Nature" volume="480" first="552" last="556">
<title>Cryptochromes mediate rhythmic repression of the glucocorticoid receptor.</title>
<authorList>
<person name="Lamia K.A."/>
<person name="Papp S.J."/>
<person name="Yu R.T."/>
<person name="Barish G.D."/>
<person name="Uhlenhaut N.H."/>
<person name="Jonker J.W."/>
<person name="Downes M."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="22170608"/>
<dbReference type="DOI" id="10.1038/nature10700"/>
</citation>
<scope>INTERACTION WITH CRY1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2012" name="Mol. Cell" volume="48" first="572" last="586">
<title>EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex.</title>
<authorList>
<person name="Lee J.M."/>
<person name="Lee J.S."/>
<person name="Kim H."/>
<person name="Kim K."/>
<person name="Park H."/>
<person name="Kim J.Y."/>
<person name="Lee S.H."/>
<person name="Kim I.S."/>
<person name="Kim J."/>
<person name="Lee M."/>
<person name="Chung C.H."/>
<person name="Seo S.B."/>
<person name="Yoon J.B."/>
<person name="Ko E."/>
<person name="Noh D.Y."/>
<person name="Kim K.I."/>
<person name="Kim K.K."/>
<person name="Baek S.H."/>
</authorList>
<dbReference type="PubMed" id="23063525"/>
<dbReference type="DOI" id="10.1016/j.molcel.2012.09.004"/>
</citation>
<scope>METHYLATION AT LYS-38</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2012" name="Trends Endocrinol. Metab." volume="23" first="619" last="627">
<title>Action of RORs and their ligands in (patho)physiology.</title>
<authorList>
<person name="Solt L.A."/>
<person name="Burris T.P."/>
</authorList>
<dbReference type="PubMed" id="22789990"/>
<dbReference type="DOI" id="10.1016/j.tem.2012.05.012"/>
</citation>
<scope>REVIEW ON FUNCTION AND LIGANDS</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2018" name="Am. J. Hum. Genet." volume="102" first="744" last="759">
<title>Dual molecular effects of dominant RORA mutations cause two variants of syndromic intellectual disability with either autism or cerebellar ataxia.</title>
<authorList>
<person name="Guissart C."/>
<person name="Latypova X."/>
<person name="Rollier P."/>
<person name="Khan T.N."/>
<person name="Stamberger H."/>
<person name="McWalter K."/>
<person name="Cho M.T."/>
<person name="Kjaergaard S."/>
<person name="Weckhuysen S."/>
<person name="Lesca G."/>
<person name="Besnard T."/>
<person name="Ounap K."/>
<person name="Schema L."/>
<person name="Chiocchetti A.G."/>
<person name="McDonald M."/>
<person name="de Bellescize J."/>
<person name="Vincent M."/>
<person name="Van Esch H."/>
<person name="Sattler S."/>
<person name="Forghani I."/>
<person name="Thiffault I."/>
<person name="Freitag C.M."/>
<person name="Barbouth D.S."/>
<person name="Cadieux-Dion M."/>
<person name="Willaert R."/>
<person name="Guillen Sacoto M.J."/>
<person name="Safina N.P."/>
<person name="Dubourg C."/>
<person name="Grote L."/>
<person name="Carre W."/>
<person name="Saunders C."/>
<person name="Pajusalu S."/>
<person name="Farrow E."/>
<person name="Boland A."/>
<person name="Karlowicz D.H."/>
<person name="Deleuze J.F."/>
<person name="Wojcik M.H."/>
<person name="Pressman R."/>
<person name="Isidor B."/>
<person name="Vogels A."/>
<person name="Van Paesschen W."/>
<person name="Al-Gazali L."/>
<person name="Al Shamsi A.M."/>
<person name="Claustres M."/>
<person name="Pujol A."/>
<person name="Sanders S.J."/>
<person name="Rivier F."/>
<person name="Leboucq N."/>
<person name="Cogne B."/>
<person name="Sasorith S."/>
<person name="Sanlaville D."/>
<person name="Retterer K."/>
<person name="Odent S."/>
<person name="Katsanis N."/>
<person name="Bezieau S."/>
<person name="Koenig M."/>
<person name="Davis E.E."/>
<person name="Pasquier L."/>
<person name="Kuery S."/>
</authorList>
<dbReference type="PubMed" id="29656859"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2018.02.021"/>
</citation>
<scope>INVOLVEMENT IN IDDECA</scope>
<scope>VARIANTS IDDECA SER-90; ALA-92; ARG-94; ARG-409; GLN-462 AND 500-ARG--GLY-523 DEL</scope>
<scope>CHARACTERIZATION OF VARIANTS IDDECA ALA-92; ARG-94 AND GLN-462</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANT ALA-476</scope>
<scope>CHARACTERIZATION OF VARIANT ALA-476</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] SER-18 (ISOFORM 2)</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2002" name="Structure" volume="10" first="1697" last="1707">
<title>X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha.</title>
<authorList>
<person name="Kallen J.A."/>
<person name="Schlaeppi J.-M."/>
<person name="Bitsch F."/>
<person name="Geisse S."/>
<person name="Geiser M."/>
<person name="Delhon I."/>
<person name="Fournier B."/>
</authorList>
<dbReference type="PubMed" id="12467577"/>
<dbReference type="DOI" id="10.1016/s0969-2126(02)00912-7"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.63 ANGSTROMS) OF 271-523 IN COMPLEX WITH CHOLESTEROL</scope>
<scope>FUNCTION AS TRANSCRIPTION ACTIVATOR</scope>
<scope>IDENTIFICATION OF LIGANDS</scope>
<scope>MUTAGENESIS OF CYS-323; ALA-330; ALA-371; PHE-399; HIS-484 AND TYR-507</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="14033" last="14038">
<title>Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A.</title>
<authorList>
<person name="Kallen J."/>
<person name="Schlaeppi J.-M."/>
<person name="Bitsch F."/>
<person name="Delhon I."/>
<person name="Fournier B."/>
</authorList>
<dbReference type="PubMed" id="14722075"/>
<dbReference type="DOI" id="10.1074/jbc.m400302200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 271-523 IN COMPLEX WITH CHOLESTEROL SULFATE</scope>
<scope>MUTAGENESIS OF CYS-288; CYS-323; ALA-330; LYS-339 AND GLU-509</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<comment type="function">
<text evidence="8 9 10 11 12 13 15 16 17 18 19 20 21 23 24 28 30 31 32">Nuclear receptor that binds DNA as a monomer to ROR response elements (RORE) containing a single core motif half-site 5'-AGGTCA-3' preceded by a short A-T-rich sequence. Key regulator of embryonic development, cellular differentiation, immunity, circadian rhythm as well as lipid, steroid, xenobiotics and glucose metabolism. Considered to have intrinsic transcriptional activity, have some natural ligands like oxysterols that act as agonists (25-hydroxycholesterol) or inverse agonists (7-oxygenated sterols), enhancing or repressing the transcriptional activity, respectively. Recruits distinct combinations of cofactors to target genes regulatory regions to modulate their transcriptional expression, depending on the tissue, time and promoter contexts. Regulates genes involved in photoreceptor development including OPN1SW, OPN1SM and ARR3 and skeletal muscle development with MYOD1. Required for proper cerebellum development (PubMed:29656859). Regulates SHH gene expression, among others, to induce granule cells proliferation as well as expression of genes involved in calcium-mediated signal transduction. Regulates the circadian expression of several clock genes, including CLOCK, ARNTL/BMAL1, NPAS2 and CRY1. Competes with NR1D1 for binding to their shared DNA response element on some clock genes such as ARNTL/BMAL1, CRY1 and NR1D1 itself, resulting in NR1D1-mediated repression or RORA-mediated activation of clock genes expression, leading to the circadian pattern of clock genes expression. Therefore influences the period length and stability of the clock. Regulates genes involved in lipid metabolism such as apolipoproteins APOA1, APOA5, APOC3 and PPARG. In liver, has specific and redundant functions with RORC as positive or negative modulator of expression of genes encoding phase I and phase II proteins involved in the metabolism of lipids, steroids and xenobiotics, such as CYP7B1 and SULT2A1. Induces a rhythmic expression of some of these genes. In addition, interplays functionally with NR1H2 and NR1H3 for the regulation of genes involved in cholesterol metabolism. Also involved in the regulation of hepatic glucose metabolism through the modulation of G6PC and PCK1. In adipose tissue, plays a role as negative regulator of adipocyte differentiation, probably acting through dual mechanisms. May suppress CEBPB-dependent adipogenesis through direct interaction and PPARG-dependent adipogenesis through competition for DNA-binding. Downstream of IL6 and TGFB and synergistically with RORC isoform 2, is implicated in the lineage specification of uncommitted CD4(+) T-helper (T(H)) cells into T(H)17 cells, antagonizing the T(H)1 program. Probably regulates IL17 and IL17F expression on T(H) by binding to the essential enhancer conserved non-coding sequence 2 (CNS2) in the IL17-IL17F locus. Involved in hypoxia signaling by interacting with and activating the transcriptional activity of HIF1A. May inhibit cell growth in response to cellular stress. May exert an anti-inflammatory role by inducing CHUK expression and inhibiting NF-kappa-B signaling.</text>
</comment>
<comment type="subunit">
<text evidence="5 8 12 14 20 21 25 26 30 31 32">Monomer. Interacts (via the DNA-binding domain) with HIF1A; the interaction enhances HIF1A transcription under hypoxia through increasing protein stability. Interacts with CEBPB; the interaction disrupts the interaction CEBPB:EP300. Interacts with the coactivators NCOA2, PPARGC1A (via LXXLL motif), EP300 and MED1. Interacts with the corepressor NCOR1. Interacts with MAGED1 and CTNNB1. Interacts with CRY1 and PER2. Interacts (via AF-2 motif) with PROX1 (By similarity). Interacts with NRIP1. Isoform 4 interacts (via AF-2 motif) with isoform 1 of FOXP3 (via LXXLL motif).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748689">
<id>P35398</id>
</interactant>
<interactant intactId="EBI-744302">
<id>P14136</id>
<label>GFAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-748689">
<id>P35398</id>
</interactant>
<interactant intactId="EBI-946109">
<id>P51843</id>
<label>NR0B1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11295807">
<id>P35398-4</id>
</interactant>
<interactant intactId="EBI-983719">
<id>Q9BZS1</id>
<label>FOXP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="6 19 20 21">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative promoter"/>
<event type="alternative splicing"/>
<isoform>
<id>P35398-2</id>
<name>1</name>
<name>Alpha-1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P35398-1</id>
<name>2</name>
<name>Alpha-2</name>
<sequence type="described" ref="VSP_053973"/>
</isoform>
<isoform>
<id>P35398-3</id>
<name>3</name>
<name>Alpha-3</name>
<sequence type="described" ref="VSP_053975"/>
</isoform>
<isoform>
<id>P35398-4</id>
<name>4</name>
<name>Alpha-4</name>
<sequence type="described" ref="VSP_053974"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="20 28 29">Widely expressed in a number of tissues. Expressed in both regulatory T-cells (Treg) and effector T-cells (Teff) (PubMed:18354202, PubMed:7916608). Isoform 4: Highly expressed in the central nervous system, including in the cerebellum (PubMed:29656859).</text>
</comment>
<comment type="induction">
<text evidence="17 21">Induced by oxidative stress and DNA damage. Isoform 4 is induced by hypoxia (through transactivation by HIF1A and SP1), but not isoform 1.</text>
</comment>
<comment type="domain">
<text evidence="4">The AF-2 (activation function-2) motif is required for recruiting coregulators containing LXXLL motifs.</text>
</comment>
<comment type="PTM">
<text evidence="18 19">Phosphorylation by conventional PKCs in neurons inhibits transcriptional activity. Phosphorylated on Thr-183 by MAPK1/ERK1 in vitro.</text>
</comment>
<comment type="PTM">
<text evidence="22">Sumoylated by SENP1 and SENP2. Sumoylation, promoted by PIAS2, PIAS3, PIAS4 but not PIAS1, enhances the transcriptional activity. Desumoylated by SENP1.</text>
</comment>
<comment type="PTM">
<text evidence="13">Ubiquitinated, leading to its degradation by the proteasome. Proteasomal degradation is required for efficient transcriptional activity and is prevented by HR.</text>
</comment>
<comment type="PTM">
<molecule>Isoform 1</molecule>
<text evidence="13">monomethylated at Lys-38 by EZH2, this creates a degron recognized by a DCX (DDB1-DCAF1/VPRBP-CUL4A-RBX1) E3 ubiquitin ligase complex.</text>
</comment>
<comment type="disease" evidence="28">
<disease id="DI-05291">
<name>Intellectual developmental disorder with or without epilepsy or cerebellar ataxia</name>
<acronym>IDDECA</acronym>
<description>An autosomal dominant neurodevelopmental disorder that manifests with variable features of mild-to-severe intellectual disability, developmental delay, autism spectrum disorder, cerebellar ataxia and epilepsy.</description>
<dbReference type="MIM" id="618060"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 2</molecule>
<text evidence="37">Produced by alternative promoter usage. Region from 23 to 71 inhibits DNA-binding and transactivation activity.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 3</molecule>
<text evidence="37">Produced by alternative splicing.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 4</molecule>
<text evidence="37">Produced by alternative promoter usage.</text>
</comment>
<comment type="similarity">
<text evidence="37">Belongs to the nuclear hormone receptor family. NR1 subfamily.</text>
</comment>
<dbReference type="EMBL" id="U04897">
<property type="protein sequence ID" value="AAA62658.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U04898">
<property type="protein sequence ID" value="AAA62659.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U04899">
<property type="protein sequence ID" value="AAA62660.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L14611">
<property type="protein sequence ID" value="AAA02963.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="HQ692818">
<property type="protein sequence ID" value="ADZ17329.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC009560">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC012404">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC022898">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC079068">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC087385">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC107241">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC107905">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471082">
<property type="protein sequence ID" value="EAW77594.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC008831">
<property type="protein sequence ID" value="AAH08831.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC100987">
<property type="protein sequence ID" value="AAI00988.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC100988">
<property type="protein sequence ID" value="AAI00989.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC100989">
<property type="protein sequence ID" value="AAI00990.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC100990">
<property type="protein sequence ID" value="AAI00991.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10177.1">
<molecule id="P35398-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10179.1">
<molecule id="P35398-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45271.1">
<molecule id="P35398-4"/>
</dbReference>
<dbReference type="PIR" id="A53196">
<property type="entry name" value="A53196"/>
</dbReference>
<dbReference type="PIR" id="A56856">
<property type="entry name" value="A56856"/>
</dbReference>
<dbReference type="PIR" id="B53196">
<property type="entry name" value="B53196"/>
</dbReference>
<dbReference type="PIR" id="C53196">
<property type="entry name" value="C53196"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002934.1">
<property type="nucleotide sequence ID" value="NM_002943.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_599022.1">
<molecule id="P35398-1"/>
<property type="nucleotide sequence ID" value="NM_134260.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_599023.1">
<molecule id="P35398-2"/>
<property type="nucleotide sequence ID" value="NM_134261.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_599024.1">
<property type="nucleotide sequence ID" value="NM_134262.2"/>
</dbReference>
<dbReference type="PDB" id="1N83">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.63"/>
<property type="chains" value="A=271-523"/>
</dbReference>
<dbReference type="PDB" id="1S0X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=271-523"/>
</dbReference>
<dbReference type="PDB" id="4S15">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=269-523"/>
</dbReference>
<dbReference type="PDBsum" id="1N83"/>
<dbReference type="PDBsum" id="1S0X"/>
<dbReference type="PDBsum" id="4S15"/>
<dbReference type="SMR" id="P35398"/>
<dbReference type="BioGRID" id="112022">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="DIP" id="DIP-29938N"/>
<dbReference type="IntAct" id="P35398">
<property type="interactions" value="9"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000261523"/>
<dbReference type="BindingDB" id="P35398"/>
<dbReference type="ChEMBL" id="CHEMBL5868"/>
<dbReference type="DrugBank" id="DB04540">
<property type="generic name" value="Cholesterol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01990">
<property type="generic name" value="Cholesterol sulfate"/>
</dbReference>
<dbReference type="DrugCentral" id="P35398"/>
<dbReference type="GuidetoPHARMACOLOGY" id="598"/>
<dbReference type="iPTMnet" id="P35398"/>
<dbReference type="PhosphoSitePlus" id="P35398"/>
<dbReference type="BioMuta" id="RORA"/>
<dbReference type="DMDM" id="548814"/>
<dbReference type="jPOST" id="P35398"/>
<dbReference type="MassIVE" id="P35398"/>
<dbReference type="PaxDb" id="P35398"/>
<dbReference type="PeptideAtlas" id="P35398"/>
<dbReference type="PRIDE" id="P35398"/>
<dbReference type="ProteomicsDB" id="55055">
<molecule id="P35398-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55056">
<molecule id="P35398-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55057">
<molecule id="P35398-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55058">
<molecule id="P35398-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="4080">
<property type="antibodies" value="547 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000261523">
<molecule id="P35398-1"/>
<property type="protein sequence ID" value="ENSP00000261523"/>
<property type="gene ID" value="ENSG00000069667"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000335670">
<molecule id="P35398-2"/>
<property type="protein sequence ID" value="ENSP00000335087"/>
<property type="gene ID" value="ENSG00000069667"/>
</dbReference>
<dbReference type="GeneID" id="6095"/>
<dbReference type="KEGG" id="hsa:6095"/>
<dbReference type="UCSC" id="uc002agt.5">
<molecule id="P35398-2"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6095"/>
<dbReference type="DisGeNET" id="6095"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000069667.15"/>
<dbReference type="GeneCards" id="RORA"/>
<dbReference type="HGNC" id="HGNC:10258">
<property type="gene designation" value="RORA"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000069667">
<property type="expression patterns" value="Tissue enhanced (skin)"/>
</dbReference>
<dbReference type="MalaCards" id="RORA"/>
<dbReference type="MIM" id="600825">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="618060">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P35398"/>
<dbReference type="OpenTargets" id="ENSG00000069667"/>
<dbReference type="PharmGKB" id="PA34630"/>
<dbReference type="eggNOG" id="KOG4216">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157387"/>
<dbReference type="InParanoid" id="P35398"/>
<dbReference type="KO" id="K08532"/>
<dbReference type="OMA" id="FKSLAGC"/>
<dbReference type="OrthoDB" id="583704at2759"/>
<dbReference type="TreeFam" id="TF319910"/>
<dbReference type="PathwayCommons" id="P35398"/>
<dbReference type="Reactome" id="R-HSA-1368082">
<property type="pathway name" value="RORA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1989781">
<property type="pathway name" value="PPARA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-383280">
<property type="pathway name" value="Nuclear Receptor transcription pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4090294">
<property type="pathway name" value="SUMOylation of intracellular receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P35398"/>
<dbReference type="SIGNOR" id="P35398"/>
<dbReference type="BioGRID-ORCS" id="6095">
<property type="hits" value="3 hits in 893 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="RORA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P35398"/>
<dbReference type="GeneWiki" id="RAR-related_orphan_receptor_alpha"/>
<dbReference type="GenomeRNAi" id="6095"/>
<dbReference type="Pharos" id="P35398">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P35398"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 15"/>
</dbReference>
<dbReference type="RNAct" id="P35398">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000069667">
<property type="expression patterns" value="Expressed in lateral nuclear group of thalamus and 231 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P35398">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P35398">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008013">
<property type="term" value="F:beta-catenin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000247"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0098531">
<property type="term" value="F:ligand-activated transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004879">
<property type="term" value="F:nuclear receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0008142">
<property type="term" value="F:oxysterol binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000977">
<property type="term" value="F:RNA polymerase II transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0043565">
<property type="term" value="F:sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001223">
<property type="term" value="F:transcription coactivator binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001222">
<property type="term" value="F:transcription corepressor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071347">
<property type="term" value="P:cellular response to interleukin-1"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0036315">
<property type="term" value="P:cellular response to sterol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021930">
<property type="term" value="P:cerebellar granule cell precursor proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021702">
<property type="term" value="P:cerebellar Purkinje cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046068">
<property type="term" value="P:cGMP metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042632">
<property type="term" value="P:cholesterol homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032922">
<property type="term" value="P:circadian regulation of gene expression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030522">
<property type="term" value="P:intracellular receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042692">
<property type="term" value="P:muscle cell differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045599">
<property type="term" value="P:negative regulation of fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043124">
<property type="term" value="P:negative regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050728">
<property type="term" value="P:negative regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006809">
<property type="term" value="P:nitric oxide biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042753">
<property type="term" value="P:positive regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010575">
<property type="term" value="P:positive regulation of vascular endothelial growth factor production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010906">
<property type="term" value="P:regulation of glucose metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043030">
<property type="term" value="P:regulation of macrophage activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008589">
<property type="term" value="P:regulation of smoothened signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019218">
<property type="term" value="P:regulation of steroid metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060850">
<property type="term" value="P:regulation of transcription involved in cell fate commitment"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072539">
<property type="term" value="P:T-helper 17 cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070328">
<property type="term" value="P:triglyceride homeostasis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006805">
<property type="term" value="P:xenobiotic metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.565.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.50.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00550"/>
<dbReference type="InterPro" id="IPR035500">
<property type="entry name" value="NHR-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000536">
<property type="entry name" value="Nucl_hrmn_rcpt_lig-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001723">
<property type="entry name" value="Nuclear_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR003079">
<property type="entry name" value="ROR_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR001628">
<property type="entry name" value="Znf_hrmn_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR013088">
<property type="entry name" value="Znf_NHR/GATA"/>
</dbReference>
<dbReference type="Pfam" id="PF00104">
<property type="entry name" value="Hormone_recep"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00105">
<property type="entry name" value="zf-C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01293">
<property type="entry name" value="RORNUCRECPTR"/>
</dbReference>
<dbReference type="PRINTS" id="PR00398">
<property type="entry name" value="STRDHORMONER"/>
</dbReference>
<dbReference type="PRINTS" id="PR00047">
<property type="entry name" value="STROIDFINGER"/>
</dbReference>
<dbReference type="SMART" id="SM00430">
<property type="entry name" value="HOLI"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00399">
<property type="entry name" value="ZnF_C4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48508">
<property type="entry name" value="SSF48508"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51843">
<property type="entry name" value="NR_LBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00031">
<property type="entry name" value="NUCLEAR_REC_DBD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51030">
<property type="entry name" value="NUCLEAR_REC_DBD_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0877">Alternative promoter usage</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Nuclear receptor ROR-alpha" id="PRO_0000053512">
<location>
<begin position="1"/>
<end position="523"/>
</location>
</feature>
<feature type="domain" description="NR LBD" evidence="7">
<location>
<begin position="272"/>
<end position="510"/>
</location>
</feature>
<feature type="DNA-binding region" description="Nuclear receptor" evidence="6">
<location>
<begin position="73"/>
<end position="138"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="6">
<location>
<begin position="73"/>
<end position="93"/>
</location>
</feature>
<feature type="zinc finger region" description="NR C4-type" evidence="6">
<location>
<begin position="109"/>
<end position="133"/>
</location>
</feature>
<feature type="short sequence motif" description="AF-2">
<location>
<begin position="506"/>
<end position="523"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="166"/>
<end position="169"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine" evidence="27">
<location>
<position position="38"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by MAPK1" evidence="18">
<location>
<position position="183"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="22">
<location>
<position position="240"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_053973" evidence="35">
<original>MESAPAAPDPAASEPGSSGADAAAGSRETPLNQESARKSEPPAPVRRQSYSSTSRGISVTKKTHTS</original>
<variation>MNEGAPGDSDLETEARVPWSIMGHCLRTGQARMSATPTPAGEGARRDELFGILQILHQCILSSGDAFVLTGVCCSWRQNGKPPYSQKEDKEVQTGYMNA</variation>
<location>
<begin position="1"/>
<end position="66"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_053974" evidence="33 34 36">
<original>MESAPAAPDPAASEPGSSGADAAAGSRETPLNQESARKSEPPAPVRRQSYSSTSRGISVTKKTHT</original>
<variation>MMYFVIAAMK</variation>
<location>
<begin position="1"/>
<end position="65"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_053975" evidence="35">
<original>KSEPPAPVRRQSYSSTSRGISVTKKTHT</original>
<variation>SSSTCSSLSRLFWSQLEHINWDGATAKNFINLREFFSFLLPALRK</variation>
<location>
<begin position="38"/>
<end position="65"/>
</location>
</feature>
<feature type="sequence variant" description="In IDDECA; unknown pathological significance." id="VAR_081089" evidence="28">
<original>C</original>
<variation>S</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="sequence variant" description="In IDDECA; deleterious effect on embryonic development, when assayed in a heterologous system; dbSNP:rs1555427498." id="VAR_081090" evidence="28">
<original>G</original>
<variation>A</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" description="In IDDECA; deleterious effect on embryonic development, when assayed in a heterologous system; dbSNP:rs1555427497." id="VAR_081091" evidence="28">
<original>K</original>
<variation>R</variation>
<location>
<position position="94"/>
</location>
</feature>
<feature type="sequence variant" description="In IDDECA." id="VAR_081092" evidence="28">
<original>S</original>
<variation>R</variation>
<location>
<position position="409"/>
</location>
</feature>
<feature type="sequence variant" description="In IDDECA; loss of function in cerebellar development, when assayed in a heterologous system; dbSNP:rs1433850094." id="VAR_081093" evidence="28">
<original>R</original>
<variation>Q</variation>
<location>
<position position="462"/>
</location>
</feature>
<feature type="sequence variant" description="No effect on cerebellar development, when assayed in a heterologous system; dbSNP:rs190933482." id="VAR_081094" evidence="28">
<original>T</original>
<variation>A</variation>
<location>
<position position="476"/>
</location>
</feature>
<feature type="sequence variant" description="In IDDECA; unknown pathological significance." id="VAR_081095" evidence="28">
<location>
<begin position="500"/>
<end position="523"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly increased transcriptional activity. Decrease in repression by NR1D1." evidence="18">
<original>T</original>
<variation>A</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some increase in transcriptional activity. No change in repression by NR1D1." evidence="18">
<original>T</original>
<variation>D</variation>
<variation>E</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="mutagenesis site" description="Attenuates transcriptional activity." evidence="18">
<original>T</original>
<variation>R</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="mutagenesis site" description="Some increase in transcriptional activity." evidence="18">
<original>T</original>
<variation>V</variation>
<variation>I</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of sumoylation." evidence="22">
<original>K</original>
<variation>R</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="mutagenesis site" description="Less effect on transcriptional activity with cholesterol sulfate as substrate as compared to cholesterol as substrate." evidence="14">
<original>C</original>
<variation>Q</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="mutagenesis site" description="About 60% loss of transcriptional activity." evidence="12 14">
<original>C</original>
<variation>L</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="mutagenesis site" description="About 80% loss of transcriptional activity." evidence="12 14">
<original>A</original>
<variation>L</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreases interaction with NCOA2 and MED1." evidence="8">
<original>V</original>
<variation>R</variation>
<location>
<position position="335"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of transcriptional activity; when associated with A-507." evidence="14">
<original>K</original>
<variation>A</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased transcriptional activity. No effect on protein degradation." evidence="13">
<original>K</original>
<variation>A</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="mutagenesis site" description="Small reduction in transcriptional activity. No protein degradation." evidence="13">
<original>L</original>
<variation>F</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="mutagenesis site" description="Greatly reduced transcriptional activity. Protects from protein degradation." evidence="13">
<original>V</original>
<variation>G</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost total loss of transcriptional activity." evidence="12">
<original>A</original>
<variation>Q</variation>
<location>
<position position="371"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slight loss of transcriptional activity." evidence="12">
<original>F</original>
<variation>W</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on sumoylation." evidence="22">
<original>K</original>
<variation>R</variation>
<location>
<position position="441"/>
</location>
</feature>
<feature type="mutagenesis site" description="Almost total loss of transcriptional activity." evidence="12">
<original>H</original>
<variation>W</variation>
<location>
<position position="484"/>
</location>
</feature>
<feature type="mutagenesis site" description="Complete loss of transcriptional activity; when associated with A-339." evidence="12">
<original>Y</original>
<variation>A</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="mutagenesis site" description="About 40% loss of transcriptional activity." evidence="12">
<original>Y</original>
<variation>F</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes transcriptional activity. Protects from protein degradation." evidence="13 14">
<original>E</original>
<variation>K</variation>
<location>
<position position="509"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases interaction with NCOA2. Loss of interaction with FOXP3." evidence="8 20">
<original>LF</original>
<variation>AA</variation>
<location>
<begin position="510"/>
<end position="511"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA02963." ref="2" evidence="37">
<original>M</original>
<variation>V</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA02963." ref="2" evidence="37">
<original>I</original>
<variation>M</variation>
<location>
<position position="466"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="271"/>
<end position="286"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="292"/>
<end position="297"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="298"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="305"/>
<end position="313"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="316"/>
<end position="340"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="342"/>
<end position="346"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="349"/>
<end position="367"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="368"/>
<end position="371"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="374"/>
<end position="377"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="378"/>
<end position="381"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="384"/>
<end position="386"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="388"/>
<end position="394"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="397"/>
<end position="411"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="412"/>
<end position="414"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="417"/>
<end position="428"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="439"/>
<end position="460"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="466"/>
<end position="494"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="496"/>
<end position="502"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="505"/>
<end position="510"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample, somatic mutation." id="VAR_082877" evidence="3">
<original>P</original>
<variation>S</variation>
<location sequence="P35398-1">
<position position="18"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA02963." ref="2" evidence="37">
<original>A</original>
<variation>E</variation>
<location sequence="P35398-4">
<position position="7"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1N83"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4S15"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P51448"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00407"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01189"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10478845"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11053433"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11252722"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11554739"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12467577"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14570920"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14722075"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15781255"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15790933"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16462772"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17512500"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18005000"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18354202"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18658046"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19041634"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19965867"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21499262"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21628546"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22170608"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23063525"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29656859"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7916608"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7926749"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9328355"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9862959"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7916608"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7926749"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="37" type="ECO:0000305"/>
<sequence length="523" mass="58975" checksum="0FA43BBCE6E28DC7" modified="2014-04-16" version="2">MESAPAAPDPAASEPGSSGADAAAGSRETPLNQESARKSEPPAPVRRQSYSSTSRGISVTKKTHTSQIEIIPCKICGDKSSGIHYGVITCEGCKGFFRRSQQSNATYSCPRQKNCLIDRTSRNRCQHCRLQKCLAVGMSRDAVKFGRMSKKQRDSLYAEVQKHRMQQQQRDHQQQPGEAEPLTPTYNISANGLTELHDDLSNYIDGHTPEGSKADSAVSSFYLDIQPSPDQSGLDINGIKPEPICDYTPASGFFPYCSFTNGETSPTVSMAELEHLAQNISKSHLETCQYLREELQQITWQTFLQEEIENYQNKQREVMWQLCAIKITEAIQYVVEFAKRIDGFMELCQNDQIVLLKAGSLEVVFIRMCRAFDSQNNTVYFDGKYASPDVFKSLGCEDFISFVFEFGKSLCSMHLTEDEIALFSAFVLMSADRSWLQEKVKIEKLQQKIQLALQHVLQKNHREDGILTKLICKVSTLRALCGRHTEKLMAFKAIYPDIVRLHFPPLYKELFTSEFEPAMQIDG</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

